Talk with a clinic navigator Call us +1 (800) 923-7404
TREATMENT GUIDE · OPTIONS TO EXPLORE

Pulsed Electric Field (PEF) ablation

Emerging approaches

Emerging nonthermal local ablation for selected soft-tissue and lung tumors, with some uses still being evaluated in clinical studies

Pulsed electric field ablation uses very short, high-voltage electrical pulses to damage cell membranes and destroy a planned area of soft tissue without relying primarily on heat or freezing. Cancer programs may deliver it through a needle placed through the skin, during surgery, or through a robotic bronchoscope. It is a local treatment for selected tumors, not a whole-body cancer cure, and availability depends on the tumor, anatomy, device, clinical program, and whether treatment is routine care or research.

Information checked 2026-10-07 View sources ↓
A PLACE TO BEGIN

About this approach

Pulsed electric field ablation uses very short, high-voltage electrical pulses to damage cell membranes and destroy a planned area of soft tissue without relying primarily on heat or freezing. Cancer programs may deliver it through a needle placed through the skin, during surgery, or through a robotic bronchoscope. It is a local treatment for selected tumors, not a whole-body cancer cure, and availability depends on the tumor, anatomy, device, clinical program, and whether treatment is routine care or research.

Where it fits: Emerging nonthermal local ablation for selected soft-tissue and lung tumors, with some uses still being evaluated in clinical studies

CURRENT CLINICAL USE

Where this treatment is used

The U.S. Aliya system has FDA 510(k) clearance as an electrosurgical device for soft-tissue ablation, but its clearance is not a blanket approval for every cancer, tumor location, or claimed immune effect. Centers currently describe selected use in lung, liver, gastrointestinal, metastatic, or other reachable soft-tissue lesions. Early prospective studies and active trials are assessing safety, local control, and possible immune effects.

WHAT TREATMENT MAY INVOLVE

Procedure and practical considerations

Treatment may require sedation or general anesthesia and image-guided placement of a needle or bronchoscopic catheter. Risks depend on the target and access route and may include pain, bleeding, infection, pneumothorax for lung procedures, injury to nearby structures, incomplete ablation, and the need for repeat or additional treatment. Some implanted electronic devices or other medical conditions may affect eligibility. Patients should receive a written imaging and follow-up plan and know who will manage complications. PEF cancer ablation is different from cardiac pulsed-field ablation, from histotripsy, and from NanoKnife irreversible electroporation; the device, pulse pattern, evidence, and clinical indications are not interchangeable.

EXPLORE YOUR OPTIONS

Clinics reporting this approach

These clinic profiles mention this approach in their published materials. Open a profile to compare locations, services, practical details, and ways to get started.

Browse all 14 connected profiles
FOLLOW THE INFORMATION

Sources

Source information checked: 2026-10-07. The links below identify the public and clinic-provided materials used for this page.

Compiled by: Cancer Clinic Finder Editorial Team

  1. FDA 510(k) K232420: Aliya System decision summary ↗Checked 2026-10-07
  2. National Cancer Institute: active phase I PEF trial for metastatic breast-cancer lesions ↗Checked 2026-10-07
  3. Galvanize Therapeutics: Aliya PEF system, indications and limitations ↗Checked 2026-10-07
  4. Roswell Park: patient guide to PEF ablation ↗Checked 2026-10-07
  5. Duke Health: PEF ablation for selected lung tumors ↗Checked 2026-10-07

How Cancer Clinic Finder compiles information · Suggest a factual correction

REQUEST A CALLBACK

Request a callback.

Tell us the best number to reach you. A clinic navigator will call to help you explore treatment centers.

This request goes to our team, not to a clinic. Please do not include medical records or sensitive health information.

+1 (800) 923-7404 What happens on the call ↗